Prevalence of BRCA1 and BRCA2 mutations in Ovarian Cancer patients in the Gulf region

Trial Identifier:	D133FR00118
Sponsor:	AstraZeneca
NCTID::	NCT03082976
Start Date:	July 2017
Primary Completion Date:	July 2019
Condition:	Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Arab Emirates	AL AIN, United Arab Emirates

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.